Publications

Publication of research results is a pivotal requirement for a comprehensive improvement of treatment concepts. iOMEDICO supports the international guidelines for transparency and reporting of medical research results.

We regularly present our data at national and international conferences. Our publications are published in scientifically renowned, international journals. Authors are principal investigators, investigators with a high number of participating patients, and scientists of iOMEDICO.

TITEL
STUDIE
JAHR
Bendamustine in the treatment of chronic lymphocytic leukemia.

Knauf, W., 2009

Expert Rev Anticancer Ther 9, 165–174. doi:10.1586/14737140.9.2.165

Abstract

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: - / Journal: Expert Review of Anticancer Therapy
02 CLL III
2009
The effect of exemestane or tamoxifen on markers of bone turnover: results of a German sub-study of the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial.

Hadji, P., Ziller, M., Kieback, D.G., Menschik, T., Kalder, M., Kuck, J., Hasenburg, A., 2009.

Breast 18, 159–164. doi:10.1016/j.breast.2009.03.003

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: The Breast
TEAM
2009
Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy.

Hadji, P., Ziller, M., Kieback, D.G., Dornoff, W., Tessen, H.W., Menschik, T., Kuck, J., Melchert, F., Hasenburg, A., 2009.

Ann Oncol 20, 1203–1209. doi:10.1093/annonc/mdn762

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: Annals of Oncology
TEAM
2009
The treatment of colorectal cancer in German outpatient centres. Data from a clinical registry. A joint project of the AIO and the AKS.

Freier, W., Schröder, J., Rauh, J., Harich, H.-D., Hartmann, H., 2009.

Onkologie 32 (suppl 4)(P197), 47. doi:10.1159/000242462

Abstract

Download

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: DGHO / Journal: Onkologie
TKK
2009
Gemcitabine plus vinorelbine versus gemcitabine plus cisplatin versus gemcitabine plus capecitabine: A randomized trial in pretreated metastatic breast cancer.

Freier, W., Stemmler, H.-J., Tessen, H.-W., Gitsch, G., Jonat, W., Bruger, W., Kettner, E., Tesch, H., Abenhardt, W., Heinemann, V., 2008.

Onkologie 31 (suppl 4)(P470), 164. doi:10.1159/000161588

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: DGHO / Journal: Onkologie
Gemcitabine 02 MC
2008
Quality of life in relation to hormonal treatment of postmenopausal women in the Dutch subset of the TEAM Trial.

van Nes, J., Voskuil, D., Putter, H., van Leeuwen, F., Junggeburt, J., Hille, E., de Haes, H., van de Velde, C., 2008.

Cancer Res 69(2 Supplement), 21. doi:10.1158/0008-5472.SABCS-21

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: SABCS / Journal: Cancer Research
TEAM
2008
Bendamustine versus chlorambucil as first-line treatment in B cell chronic lymphocytic leukemia: An updated analysis from an international phase III study.

Knauf, W.U., Lissitchkov, T., Aldaoud, A., Liberati, A., Loscertales, J., Herbrecht, R., Juliusson, G., Postner, G., Gercheva, L., Goranov, S., Becker, M., Hoeffken, K., Huguet, F., Foa, R., Merkle, K., Montillo, M., 2008.

Blood 112(11), 2091.

Abstract

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: ASH / Journal: Blood
02 CLL III
2008
Results of the first planned analysis of the TEAM (tamoxifen exemestane adjuvant multinational) prospective randomized phase III trial in hormone sensitive postmenopausalearly breast cancer.

Jones, S.E., Seynaeve, C., Hasenburg, A., Rea, D., Vannetzel, J.M., Paridaens, R., Markopoulos, C., Hozumi, Y., Putter, H., Hille, E., Kieback, D.G., Asmar, L., Smeets, J., Urbanski, R., Bartlett, J., van de Velde and D Rea, C., 2008.

Cancer Res 69(2 Supplement), 15. doi:10.1158/0008-5472.SABCS-15

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: SABCS / Journal: Cancer Research
TEAM
2008
Bone Effects of Exemestane vs. Tamoxifen within the German TEAM trial: Results of a Prospective Randomized Bone Sub-Study.

Hadji, P., Ziller, M., Kieback, D., Dornoff, W., Tessen, H., Kuck, J., Hasenburg, A., 2008.

Cancer Res 69(2 Supplement), 1143. doi:10.1158/0008-5472.SABCS-1143

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: SABCS / Journal: Cancer Research
TEAM
2008
Colon Registry: Influence of comorbidity on the choice of chemotherapeutic treatment. A joint project of the AIO and the AKS.

Freier, W., Arnold, D., Otremba, B., Marschner, N., 2008.

Onkologie 31 (suppl 4)(P301), 109. doi:10.1159/000161574

Abstract

Download

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: DGHO / Journal: Onkologie
TKK
2008